Skip to content
Clinical Trials – home
Research site

Revit Sp. z o.o.

Poland Ul. Swobodna 38, 15-756 Bialystok, Poland

  • 3 trials recruiting
  • Dementia Alzheimer's type · Chronic rhinosinusitis with nasal polyps · Major depression
  • Adult patients

About Specializations

Revit Sp. z o.o. in Bialystok, Poland specialises in clinical trials of conditions such as Dementia Alzheimer's type, Chronic rhinosinusitis with nasal polyps, Major depression, Parkinson's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Musculoskeletal Diseases

The Podlaskie Centrum Psychogeriatrii is investigating conditions such as Chronic Low Back Pain and metabolic factors that influence musculoskeletal health, aiming to improve pain management and functional outcomes.

  • Reduction of pain intensity in low back pain patients
  • Weight management strategies for obesity and overweight individuals
  • Therapeutic approaches for distal sensory polyneuropathy

At Revit Sp. z o.o., 10 clinical trials are active with 4 investigators, highlighting a strong commitment to advancing musculoskeletal care.

Nervous System Diseases

Research at the centre focuses on neurodegenerative conditions, including Alzheimer Disease and early‑stage Parkinson’s Disease, with the goal of slowing cognitive decline and preserving neurological function.

  • Cognitive impairment mitigation in early Alzheimer’s
  • Evaluation of disease‑modifying therapies for Parkinson’s
  • Study of tauopathies and broader neurodegenerative mechanisms

The site’s portfolio of 10 trials reflects a multidisciplinary effort to address the growing burden of nervous system disorders.

Respiratory Tract Diseases

The clinic conducts studies on chronic inflammatory airway conditions, notably Chronic Rhinosinusitis with Nasal Polyps, to assess new treatments that reduce polyp size and improve nasal airflow.

  • Assessment of nasal congestion relief
  • Impact of therapy on quality of life for sinus disease patients
  • Safety and tolerability of emerging biologic agents

These efforts are part of the broader research agenda of Revit Sp. z o.o., contributing to better respiratory health outcomes.

Mental Disorders

Clinical investigations include patients with Schizophrenia who have experienced cognitive impairment, seeking to gather safety data and explore adjunctive treatments that support cognition.

  • Long‑term safety monitoring in schizophrenia cohorts
  • Cognitive function assessment after adjunct therapy
  • Evaluation of placebo‑controlled outcomes

The department’s focus on mental health aligns with its mission to improve psychiatric care through evidence‑based research.

Multidisciplinary Research

Beyond disease‑specific studies, the centre addresses broader health challenges such as Obesity and metabolic risk factors, integrating insights from neurology, psychiatry, and musculoskeletal science.

  • Weight reduction interventions linked to pain improvement
  • Impact of metabolic health on cognitive and neurological outcomes
  • Cross‑disciplinary protocols to enhance overall patient wellbeing

With a total of 10 trials and a dedicated team of 4 investigators, Revit Sp. z o.o. exemplifies a collaborative approach to complex health issues.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Swobodna 3815-756 BialystokPoland
Recruiting now
3 trials
Conditions studied
11

More sites in BialystokPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

14 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:VHB937
  • Sponsor:Novartis Pharma AG
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Aluminium Hydroxide
  • Sponsor:Advantage Therapeutics GmbH
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
  • Sponsor:Prinnovation GmbH

Dementia Alzheimer's type

Not yet recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:Biogen Idec Research Limited

Neuralgia+1

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3848575
  • Sponsor:Eli Lilly & Co.

Obesity+2

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ly3437943 Sodium
  • Sponsor:Eli Lilly & Co.
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Iclepertin
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bepranemab
  • Sponsor:UCB Biopharma
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.